Hengpin Life Technology (HKG:1682) 2023 First Half Results
Key financial performance
- Revenue: HK$58.4m (down 1.9% from 1H22).
- Net loss: HK$3.71 million (loss increased by 130% compared with the first half of 2022).
- Loss per share of HK$0.005 (worse from HK$0.002 loss in 1H22).
All data shown in the table above is for the trailing 12-month (TTM) period
Shares of Hengpin Life Technology were largely unchanged from a week ago.
Risk Analysis
Before you take the next step, you should know 2 Warning Signs of Hengpin Life Technology (1 makes us a little uncomfortable!) We’ve found out.
Valuation is complicated, but we’re helping make it simple.
find out if Hengpin Life Technology It may be overvalued or undervalued by viewing our comprehensive analysis, which includes Fair value estimates, risks and caveats, dividends, insider trading and financial health.
View free analysis
Have feedback on this article? Concerned about content? keep in touch Contact us directly. Alternatively, email the editorial team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We use only an unbiased methodology to provide reviews based on historical data and analyst forecasts, and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take into account your objectives or your financial situation. Our goal is to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative material. Simply Wall St has no positions in any of the stocks mentioned.